(NASDAQ:BOSC), RISHON LE ZION, Israel, Feb. 03, 2025 (GLOBE NEWSWIRE) — BOS Better Online Solutions Ltd. (“BOS” or the “Company”) (NASDAQ: BOSC), an integrator of supply chain technologies, announced today that its Supply Chain division has secured a new $2.3 million order from one of its primary customers in the defense sector. The order is […]

(NASDAQ:TALK), NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) — Talkspace (Nasdaq: TALK), a leading behavioral healthcare company, today announced that it will release its fourth quarter and full year 2024 results on Thursday, February 20, 2025, before market open and host a conference call to review the results at 8:30am ET. Conference Call Details The

(NASDAQ:AKTX), Innovative targeted oncology company built on next-generation ADCs and a novel discovery engine Connect with the Company on Webull here BOSTON and LONDON, Feb. 03, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing next-generation precision bi-functional antibody drug conjugates (ADC) for the treatment of cancer, today announced that it

(NASDAQ:SLRX), HOUSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) announces that patient enrollment will resume in the investigator-initiated Phase 1/2 clinical trial evaluating seclidemstat in combination with azacitidine for the treatment of myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML). The trial is being conducted at the University of Texas MD

(TSX:ILLM),(Other OTC:ILLMF), TORONTO and NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) — illumin Holdings Inc. (TSX: ILLM) (OTCQB: ILLMF) (“illumin” or “Company”), a leader in digital marketing technology, today announced that Simon Cairns, Chief Executive Officer, and Elliot Muchnik, Chief Financial Officer, will present live at the Small Cap Growth Virtual Investor Conference hosted by

(NASDAQ:VOR), CAMBRIDGE, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host virtual 1×1 investor meetings at the Oppenheimer's 35th Annual Healthcare Life Sciences Conference. Oppenheimer's 35th Annual Healthcare Life Sciences ConferenceFireside Chat: Wednesday, February

(NASDAQ:AMRK), EL SEGUNDO, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) — A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (A-Mark or the Company), a leading fully integrated precious metals platform, has entered into a definitive agreement to acquire 100% of the stock of Spectrum Group International, Inc. (SGI), the parent of Stack's Bowers Galleries (SBG), one of the

(NasdaqGM:OLLI), HARRISBURG, Pa., Feb. 03, 2025 (GLOBE NEWSWIRE) — Ollie's Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) today announced the appointment of Eric van der Valk to President & Chief Executive Officer, effective February 2, 2025. In connection with his appointment to CEO, Eric van der Valk has also been added to the Company's

(TSX:SVA),(OTC US:SEOVF),(Other OTC:SEOVF),(XETRA:PSH.DE),(Frankfurt:PSH), LONDON, Ontario and BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) — Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its Cell Pouch bio-hybrid organ as a functional cure for type 1 diabetes, today announced the submission of an Investigational New Drug (IND) application with the

(NYSE:ITGR), PLANO, Texas, Feb. 03, 2025 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), will join innovators and industry leaders around the world in exhibiting at MD&M West, Feb. 4 – 6, 2025, at the Anaheim Convention Center in Anaheim, California. Integer welcomes visitors